John Plumpe is hosting a Table Topic Discussion on “Current Trends and Topics on Monetary Relief in Lanham Act Litigation in the United States” during the annual meeting.
For more information on this event, click here.
Biosimilars: Economic Issues for IP Litigation
In July 2021, the U.S. Food and Drug Administration granted a determination of interchangeability to a biosimilar drug for the first time. This approval has...